SidaGhanaV1, PascalFrancis, Corpus, bibRecord, 000132

Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa

Identifieur interne : 000132 ( PascalFrancis/Corpus ); précédent : 000131; suivant : 000133

Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa

Auteurs : S. Aidoo ; W. K. Ampofo ; J. A. M. Brandful ; S. V. Nuvor ; J. K. Ansah ; N. Nii-Trebi ; J. S. Barnor ; F. Apeagyei ; T. Sata ; D. Ofori-Adjei ; K. Ishikawa

Source :

Journal of clinical microbiology [ 0095-1137 ] ; 2001.

RBID : Pascal:02-0327136

Descripteurs français

Pascal (Inist)
- Homme, Virus immunodéficience humaine, Détection, Anticorps, Ghana, Afrique Ouest, Immunodéficit.

English descriptors

KwdEn :
- Antibody, Detection, Ghana, Human, Human immunodeficiency virus, Immune deficiency, West Africa.

Abstract

In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0095-1137`
A02	`01`			`@0 JCMIDW`
A03		`1`		`@0 J. clin. microbiol.`
A05				`@2 39`
A06				`@2 7`
A08	`01`	`1`	`ENG`	`@1 Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa`
A11	`01`	`1`		`@1 AIDOO (S.)`
A11	`02`	`1`		`@1 AMPOFO (W. K.)`
A11	`03`	`1`		`@1 BRANDFUL (J. A. M.)`
A11	`04`	`1`		`@1 NUVOR (S. V.)`
A11	`05`	`1`		`@1 ANSAH (J. K.)`
A11	`06`	`1`		`@1 NII-TREBI (N.)`
A11	`07`	`1`		`@1 BARNOR (J. S.)`
A11	`08`	`1`		`@1 APEAGYEI (F.)`
A11	`09`	`1`		`@1 SATA (T.)`
A11	`10`	`1`		`@1 OFORI-ADJEI (D.)`
A11	`11`	`1`		`@1 ISHIKAWA (K.)`
A14	`01`			`@1 Noguchi Memorial Institute for Medical Research, University of Ghana @2 Accra @3 GHA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 6 aut. @Z 7 aut. @Z 10 aut. @Z 11 aut.`
A14	`02`			`@1 National Blood Transfusion Service, Ministry of Health @2 Korle-Bu @3 GHA @Z 5 aut.`
A14	`03`			`@1 Hygiene Wing, Military Hospital @2 Accra @3 GHA @Z 8 aut.`
A14	`04`			`@1 National Institute of Infectious Diseases @2 Tokyo @3 JPN @Z 9 aut. @Z 11 aut.`
A20				`@1 2572-2575`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 17088 @5 354000096613080290`
A44				`@0 0000 @1 © 2002 INIST-CNRS. All rights reserved.`
A45				`@0 18 ref.`
A47	`01`	`1`		`@0 02-0327136`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of clinical microbiology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.
C02	`01`	`X`		`@0 002B05C03`
C02	`02`	`X`		`@0 002B05C02D`
C02	`03`	`X`		`@0 002A05`
C03	`01`	`X`	`FRE`	`@0 Homme @5 01`
C03	`01`	`X`	`ENG`	`@0 Human @5 01`
C03	`01`	`X`	`SPA`	`@0 Hombre @5 01`
C03	`02`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 02`
C03	`02`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 02`
C03	`02`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 02`
C03	`03`	`X`	`FRE`	`@0 Détection @5 05`
C03	`03`	`X`	`ENG`	`@0 Detection @5 05`
C03	`03`	`X`	`SPA`	`@0 Detección @5 05`
C03	`04`	`X`	`FRE`	`@0 Anticorps @5 06`
C03	`04`	`X`	`ENG`	`@0 Antibody @5 06`
C03	`04`	`X`	`SPA`	`@0 Anticuerpo @5 06`
C03	`05`	`X`	`FRE`	`@0 Ghana @2 NG @5 07`
C03	`05`	`X`	`ENG`	`@0 Ghana @2 NG @5 07`
C03	`05`	`X`	`SPA`	`@0 Ghana @2 NG @5 07`
C03	`06`	`X`	`FRE`	`@0 Afrique Ouest @2 NG @5 08`
C03	`06`	`X`	`ENG`	`@0 West Africa @2 NG @5 08`
C03	`06`	`X`	`SPA`	`@0 Africa occidental @2 NG @5 08`
C03	`07`	`X`	`FRE`	`@0 Immunodéficit @5 14`
C03	`07`	`X`	`ENG`	`@0 Immune deficiency @5 14`
C03	`07`	`X`	`SPA`	`@0 Inmunodeficiencia @5 14`
C07	`01`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`02`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`03`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`03`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`03`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`04`	`X`	`FRE`	`@0 Afrique @2 NG`
C07	`04`	`X`	`ENG`	`@0 Africa @2 NG`
C07	`04`	`X`	`SPA`	`@0 Africa @2 NG`
C07	`05`	`X`	`FRE`	`@0 Immunopathologie @5 20`
C07	`05`	`X`	`ENG`	`@0 Immunopathology @5 20`
C07	`05`	`X`	`SPA`	`@0 Inmunopatología @5 20`
N21				`@1 182`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 02-0327136 INIST
ET :	Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa
AU :	AIDOO (S.); AMPOFO (W. K.); BRANDFUL (J. A. M.); NUVOR (S. V.); ANSAH (J. K.); NII-TREBI (N.); BARNOR (J. S.); APEAGYEI (F.); SATA (T.); OFORI-ADJEI (D.); ISHIKAWA (K.)
AF :	Noguchi Memorial Institute for Medical Research, University of Ghana/Accra/Ghana (1 aut., 2 aut., 3 aut., 4 aut., 6 aut., 7 aut., 10 aut., 11 aut.); National Blood Transfusion Service, Ministry of Health/Korle-Bu/Ghana (5 aut.); Hygiene Wing, Military Hospital/Accra/Ghana (8 aut.); National Institute of Infectious Diseases/Tokyo/Japon (9 aut., 11 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of clinical microbiology; ISSN 0095-1137; Coden JCMIDW; Etats-Unis; Da. 2001; Vol. 39; No. 7; Pp. 2572-2575; Bibl. 18 ref.
LA :	Anglais
EA :	In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.
CC :	002B05C03; 002B05C02D; 002A05
FD :	Homme; Virus immunodéficience humaine; Détection; Anticorps; Ghana; Afrique Ouest; Immunodéficit
FG :	Lentivirus; Retroviridae; Virus; Afrique; Immunopathologie
ED :	Human; Human immunodeficiency virus; Detection; Antibody; Ghana; West Africa; Immune deficiency
EG :	Lentivirus; Retroviridae; Virus; Africa; Immunopathology
SD :	Hombre; Human immunodeficiency virus; Detección; Anticuerpo; Ghana; Africa occidental; Inmunodeficiencia
LO :	INIST-17088.354000096613080290
ID :	02-0327136

Links to Exploration step

Pascal:02-0327136

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa</title>
<author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S." last="Aidoo">S. Aidoo</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W. K." last="Ampofo">W. K. Ampofo</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brandful, J A M" sort="Brandful, J A M" uniqKey="Brandful J" first="J. A. M." last="Brandful">J. A. M. Brandful</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nuvor, S V" sort="Nuvor, S V" uniqKey="Nuvor S" first="S. V." last="Nuvor">S. V. Nuvor</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ansah, J K" sort="Ansah, J K" uniqKey="Ansah J" first="J. K." last="Ansah">J. K. Ansah</name>
<affiliation><inist:fA14 i1="02"><s1>National Blood Transfusion Service, Ministry of Health</s1>
<s2>Korle-Bu</s2>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nii Trebi, N" sort="Nii Trebi, N" uniqKey="Nii Trebi N" first="N." last="Nii-Trebi">N. Nii-Trebi</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barnor, J S" sort="Barnor, J S" uniqKey="Barnor J" first="J. S." last="Barnor">J. S. Barnor</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Apeagyei, F" sort="Apeagyei, F" uniqKey="Apeagyei F" first="F." last="Apeagyei">F. Apeagyei</name>
<affiliation><inist:fA14 i1="03"><s1>Hygiene Wing, Military Hospital</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T." last="Sata">T. Sata</name>
<affiliation><inist:fA14 i1="04"><s1>National Institute of Infectious Diseases</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ofori Adjei, D" sort="Ofori Adjei, D" uniqKey="Ofori Adjei D" first="D." last="Ofori-Adjei">D. Ofori-Adjei</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K." last="Ishikawa">K. Ishikawa</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>National Institute of Infectious Diseases</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">02-0327136</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 02-0327136 INIST</idno>
<idno type="RBID">Pascal:02-0327136</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000132</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa</title>
<author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S." last="Aidoo">S. Aidoo</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W. K." last="Ampofo">W. K. Ampofo</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brandful, J A M" sort="Brandful, J A M" uniqKey="Brandful J" first="J. A. M." last="Brandful">J. A. M. Brandful</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nuvor, S V" sort="Nuvor, S V" uniqKey="Nuvor S" first="S. V." last="Nuvor">S. V. Nuvor</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ansah, J K" sort="Ansah, J K" uniqKey="Ansah J" first="J. K." last="Ansah">J. K. Ansah</name>
<affiliation><inist:fA14 i1="02"><s1>National Blood Transfusion Service, Ministry of Health</s1>
<s2>Korle-Bu</s2>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nii Trebi, N" sort="Nii Trebi, N" uniqKey="Nii Trebi N" first="N." last="Nii-Trebi">N. Nii-Trebi</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barnor, J S" sort="Barnor, J S" uniqKey="Barnor J" first="J. S." last="Barnor">J. S. Barnor</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Apeagyei, F" sort="Apeagyei, F" uniqKey="Apeagyei F" first="F." last="Apeagyei">F. Apeagyei</name>
<affiliation><inist:fA14 i1="03"><s1>Hygiene Wing, Military Hospital</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T." last="Sata">T. Sata</name>
<affiliation><inist:fA14 i1="04"><s1>National Institute of Infectious Diseases</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ofori Adjei, D" sort="Ofori Adjei, D" uniqKey="Ofori Adjei D" first="D." last="Ofori-Adjei">D. Ofori-Adjei</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K." last="Ishikawa">K. Ishikawa</name>
<affiliation><inist:fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>National Institute of Infectious Diseases</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of clinical microbiology</title>
<title level="j" type="abbreviated">J. clin. microbiol.</title>
<idno type="ISSN">0095-1137</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of clinical microbiology</title>
<title level="j" type="abbreviated">J. clin. microbiol.</title>
<idno type="ISSN">0095-1137</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody</term>
<term>Detection</term>
<term>Ghana</term>
<term>Human</term>
<term>Human immunodeficiency virus</term>
<term>Immune deficiency</term>
<term>West Africa</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Virus immunodéficience humaine</term>
<term>Détection</term>
<term>Anticorps</term>
<term>Ghana</term>
<term>Afrique Ouest</term>
<term>Immunodéficit</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0095-1137</s0>
</fA01>
<fA02 i1="01"><s0>JCMIDW</s0>
</fA02>
<fA03 i2="1"><s0>J. clin. microbiol.</s0>
</fA03>
<fA05><s2>39</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>AIDOO (S.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>AMPOFO (W. K.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BRANDFUL (J. A. M.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>NUVOR (S. V.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ANSAH (J. K.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>NII-TREBI (N.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BARNOR (J. S.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>APEAGYEI (F.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>SATA (T.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>OFORI-ADJEI (D.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>ISHIKAWA (K.)</s1>
</fA11>
<fA14 i1="01"><s1>Noguchi Memorial Institute for Medical Research, University of Ghana</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>National Blood Transfusion Service, Ministry of Health</s1>
<s2>Korle-Bu</s2>
<s3>GHA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Hygiene Wing, Military Hospital</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>National Institute of Infectious Diseases</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA20><s1>2572-2575</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>17088</s2>
<s5>354000096613080290</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>02-0327136</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of clinical microbiology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C03</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002A05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Homme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Human</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Détection</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Detection</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Detección</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Anticorps</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Antibody</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Anticuerpo</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Ghana</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Ghana</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Ghana</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Afrique Ouest</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>West Africa</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Africa occidental</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>20</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>20</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>20</s5>
</fC07>
<fN21><s1>182</s1>
</fN21>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 02-0327136 INIST</NO>
<ET>Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa</ET>
<AU>AIDOO (S.); AMPOFO (W. K.); BRANDFUL (J. A. M.); NUVOR (S. V.); ANSAH (J. K.); NII-TREBI (N.); BARNOR (J. S.); APEAGYEI (F.); SATA (T.); OFORI-ADJEI (D.); ISHIKAWA (K.)</AU>
<AF>Noguchi Memorial Institute for Medical Research, University of Ghana/Accra/Ghana (1 aut., 2 aut., 3 aut., 4 aut., 6 aut., 7 aut., 10 aut., 11 aut.); National Blood Transfusion Service, Ministry of Health/Korle-Bu/Ghana (5 aut.); Hygiene Wing, Military Hospital/Accra/Ghana (8 aut.); National Institute of Infectious Diseases/Tokyo/Japon (9 aut., 11 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of clinical microbiology; ISSN 0095-1137; Coden JCMIDW; Etats-Unis; Da. 2001; Vol. 39; No. 7; Pp. 2572-2575; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.</EA>
<CC>002B05C03; 002B05C02D; 002A05</CC>
<FD>Homme; Virus immunodéficience humaine; Détection; Anticorps; Ghana; Afrique Ouest; Immunodéficit</FD>
<FG>Lentivirus; Retroviridae; Virus; Afrique; Immunopathologie</FG>
<ED>Human; Human immunodeficiency virus; Detection; Antibody; Ghana; West Africa; Immune deficiency</ED>
<EG>Lentivirus; Retroviridae; Virus; Africa; Immunopathology</EG>
<SD>Hombre; Human immunodeficiency virus; Detección; Anticuerpo; Ghana; Africa occidental; Inmunodeficiencia</SD>
<LO>INIST-17088.354000096613080290</LO>
<ID>02-0327136</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000132 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000132 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0327136
   |texte=   Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa

Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri